| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $48.2B | $48.3B | $45.0B | $46.2B | $46.4B | $11.1B | $7.9B | $6.0B |
| Cost of Revenue | $13.9B | $14.0B | $10.7B | $10.1B | $9.9B | $11.8B | $8.1B | $6.5B |
| Gross Profit | — | — | — | — | — | $8.2B | $5.5B | $4.3B |
| R&D Expense | $10.0B | $11.2B | $9.3B | $9.5B | $11.4B | $11.1B | $6.1B | $6.3B |
| SG&A Expense | $7.3B | $8.4B | $7.8B | $7.8B | $7.7B | $7.7B | $4.9B | $4.6B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $7.1B | $-8.9B | $8.0B | $6.3B | $7.0B | $-10.0B | $-1.1B | $1.2B |
| EPS (Basic) | $3.47 | $-4.41 | $3.88 | $2.97 | $3.15 | $-4.45 | $-0.55 | $0.71 |
| EPS (Diluted) | $3.46 | $-4.41 | $3.86 | $2.95 | $3.12 | $-4.45 | $-0.55 | $0.71 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $90.0B | $92.6B | $95.2B | $96.8B | $109.3B | $118.5B | $129.9B | $35.0B |
| Current Assets | $29.4B | $29.8B | $31.8B | $27.3B | $33.3B | $30.2B | $29.4B | $17.2B |
| Cash & Equivalents | $10.2B | $10.3B | $11.5B | $9.1B | $14.0B | $14.5B | $12.3B | $6.9B |
| Total Liabilities | $71.5B | $76.2B | $65.7B | $65.7B | $73.3B | $80.6B | $78.2B | $20.9B |
| Current Liabilities | $23.4B | $23.8B | $22.3B | $21.9B | $21.9B | $19.1B | $18.3B | $10.7B |
| Stockholders' Equity | $18.5B | $16.3B | $29.4B | $31.1B | $35.9B | $37.8B | $51.6B | $14.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $14.2B | $15.2B | $13.9B | $13.1B | $16.2B | $14.1B | $8.1B | $5.9B |
| Investing Cash Flow | $-4.1B | $-21.4B | $-2.3B | $-1.1B | $-0.5B | $-10.9B | $-9.8B | $-0.9B |
| Capital Expenditures | $1.3B | $1.2B | $1.2B | $1.1B | $1.0B | $0.8B | $0.8B | $1.0B |
| Financing Cash Flow | $-10.3B | $5.1B | $-9.4B | $-17.0B | $-16.2B | $-1.2B | $7.6B | $-3.5B |